Describing recent developments in the engineering and generation of plants as
production platforms for biopharmaceuticals, this book includes both vaccines
and monoclonal antibodies. It has a particular emphasis on targeting diseases
which predominate in less developed countries, encompassing the current state of
technologies and describing expression systems and applications. This book also
includes a variety of vaccine case studies, protecting against pervasive
infectious diseases such as rabies, influenza and HIV.